JD Health International Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Enlin Jin
Chief Executive Officer (CEO)
CN¥8.0m
Compensación total
| Porcentaje del salario del CEO | 16.0% |
| Permanencia del CEO | 2.6yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 3.4yrs |
Actualizaciones recientes de la dirección
Recent updates
JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17
JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends
Dec 07What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?
Nov 20JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 02Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital
Aug 21JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price
Aug 03JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues
Jun 08Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?
Apr 19Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
Dec 29Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?
Sep 14A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Dec 04Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Mar 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥1b |
| Dec 31 2022 | CN¥8m | CN¥1m | CN¥380m |
| Sep 30 2022 | n/a | n/a | -CN¥7m |
| Jun 30 2022 | n/a | n/a | -CN¥395m |
| Mar 31 2022 | n/a | n/a | -CN¥734m |
| Dec 31 2021 | CN¥3m | CN¥301k | -CN¥1b |
Compensación vs. Mercado: La compensación total de Enlin($USD1.11M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD677.79K).
Compensación vs. Ingresos: La compensación de Enlin ha aumentado más de un 20% en el último año.
CEO
Enlin Jin (42 yo)
2.6yrs
Permanencia
CN¥8,045,000
Compensación
Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 2.6yrs | CN¥8.05m | 0.010% CN¥ 8.9m | |
| Independent Non-Executive Director | 2yrs | CN¥602.00k | 0.00030% CN¥ 259.8k | |
| Chairman | 3.6yrs | CN¥592.08m | 0.28% CN¥ 241.1m | |
| Non-Executive Director | 3.7yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.4yrs | CN¥502.00k | 0.00018% CN¥ 155.9k | |
| Independent Non-Executive Director | 3.4yrs | CN¥502.00k | 0.00018% CN¥ 155.9k | |
| Independent Non-Executive Director | 3.1yrs | CN¥548.00k | 0.00019% CN¥ 164.5k |
3.4yrs
Permanencia media
50yo
Promedio de edad
Junta con experiencia: La junta directiva de 6618 se considera experimentada (3.4 años de antigüedad promedio).